Expression of Cav-1 in tumour cells, rather than in stromal tissue, may promote cervical squamous cell carcinoma proliferation, and correlates with high-risk HPV infection

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 1733-1740

  Sun, Jun ^a   Gao, Jun ^b   Hu, Jun Bo ^a   Fan, Li Fang ^c   Zhu, Xiao Bo ^b   Subahan, Roz ^c   Chen, Hong Lei ^c  

^a Maternal and Child Health Hospital of Hubei Province   (China)

^b Wuhan Nano Tumor Diagnosis Engineering Research Center   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Caveolin 1; Cervical cancer; Human papilloma virus; Immunofluorescence; Quantum dots

Indexed keywords

CAVEOLIN 1; CYCLINE; QUANTUM DOT;

ADULT; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IN SITU HYBRIDIZATION; INFECTION RISK; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR PROMOTION; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CAVEOLIN 1; CELL PROLIFERATION; CERVIX UTERI; FEMALE; HUMANS; MUCOUS MEMBRANE; PAPILLOMAVIRUS INFECTIONS; QUANTUM DOTS; STROMAL CELLS; UTERINE CERVICAL NEOPLASMS;

EID: 84860736032     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1703     Document Type: Article

References (33)

1. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G and Dillner J: Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633-1638, 1999.
2. Munoz N, Bosch X, de Sanjose S, Herrero R, Castellsagué X, Shah KV, Snijders PJ and Meijer CJ: Epidemiological classification of human papillomavirus types associated with cerivcal cancer. N Engl J Med 348: 518-527, 2003. (Pubitemid 36159887)
3. Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M and Lisanti MP: Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer; genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 280: 25134-25145, 2005. (Pubitemid 40934606)
4. Suzuoki M, Miyamoto M, Kato K, Hiraoka K, Oshikiri T, Nakakubo Y, Fukunaga A, Shichinohe T, Shinohara T, Itoh T, et al: Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 87: 1140-1144, 2002. (Pubitemid 35418110)
5. Van den Eynden GG, van Laere SJ, van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY and van Golen KL: Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 95: 219-228, 2006.
6. Fine SW, Lisanti MP, Galbiati F and Li M: Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol 115: 719-724, 2001. (Pubitemid 33051539)
7. Xue J, Chen H, Diao L, Chen X and Xia D: Expression of caveolin-1 in tongue squamous cell carcinoma by quantum dots. Eur J Histochem 54: 99-103, 2010.
8. Kato K, Hida Y, Miyamoto M, Shinohara T, Itoh T, Okushiba S, Kondo S and Katoh H: Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94: 929-933, 2002. (Pubitemid 34150846)
9. Wikman H, Seppanen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, Nagy B, Karjalainen A, Sioris T, et al: Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. J Pathol 203: 584-593, 2004. (Pubitemid 38529039)
10. Bender FC, Reymond MA, Bron C and Quest AF: Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60: 5870-5878, 2000.
11. Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A and Reich R: Caveolin-1 expression in advanced-stage ovarian carcinoma: a clinicopathologic study. Gynecol Oncol 81: 166-171, 2001. (Pubitemid 32424155)
12. Park SS, Kim JE, Kim YA, Kim YC and Kim SW: Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 47: 625-630, 2005. (Pubitemid 41775186)
13. Sloan EK, Stanley KL and Anderson RL: Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23: 7893-7897, 2004. (Pubitemid 39457039)
14. Burgermeister E, Xing X, Röcken C, Juhasz M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM and Ebert MP: Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res 67: 8519-8526, 2007. (Pubitemid 47437426)
15. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C and Eng C: Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63: 2864-2871, 2003.
16. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, Kleer CG, Brody JR and Lisanti MP: An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 174: 2023-2034, 2009.
17. Chen H, Xue J, Zhang Y, Gao J and Yu B: Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol 40: 261-268, 2009.
18. Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y and Kuwabara Y: The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep 8: 601-609, 2007.
19. Goetz JG, Lajoie P, Wiseman SM and Nabi IR: Caveolin-1 in tumor progression; the good, the bad and the ugly. Cancer Metastasis Rev 27: 715-735, 2008.
20. Cassoni P, Daniele L, Maldi E, Righi L, Tavaglione V, Novello S, Volante M, Scagliotti GV and Papotti M: Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases. Histopathology 55: 20-27, 2009.
21. Kunze E, Von Bonin F, Werner C, Wendt M and Schlott T: Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Int J Mol Med 17: 3-13, 2006.
22. Chen HL, Fan LF, Gao J, Ouyang JP and Zhang YX: Differential expression and function of caveolin-1 gene in non-small cell lung carcinoma. Oncol Rep 25: 359-366, 2011.
23. Du ZM, Hu CF, Shao Q, Huang MY, Kou CW, Zhu XF, Zeng YX and Shao JY: Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 125: 1832-1841, 2009.
24. Zhang H, Su L, Müller S, Tighiouart M, Xu Z, Zhang X, Shin HJ, Hunt J, Sun SY, Shin DM and Chen ZG: Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer 99: 1684-1694, 2008.
25. Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, et al: Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol 38: 209-217, 2011.
26. Chan TF, Su TH, Yeh KT, Chang JY, Lin TH, Chen JC, Yuang SS and Chang JG: Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Int J Oncol 23: 599-604, 2003.
27. Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ and Li M: Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am J Clin Pathol 120: 93-100, 2003. (Pubitemid 37046375)
28. Yoo SH, Park YS, Kim HR, Sung SW, Kim JH, Shim YS, Lee SD, Choi YL, Kim MK and Chung DH: Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. Lung Cancer 42: 195-202, 2003. (Pubitemid 37268030)
29. Sloan EK, Ciocca DR, Pouliot N, Natoli A, Restall C, Henderson MA, Fanelli MA, Cuello-Carrión FD, Gago FE and Anderson RL: Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 174: 2035-2043, 2009.
30. Qian N, Ueno T, Kawaguchi-Sakita N, Kawashima M, Yoshida N, Mikami Y, Wakasa T, Shintaku M, Tsuyuki S, Inamoto T and Toi M: Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients. Cancer Sci 102: 1590-1596, 2011.
31. Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR and Lisanti MP: An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 8: 2420-2424, 2009.
32. Li ZH, Peng J and Chen HL: Bioconjugated quantum dots as fluorescent probes for biomedical imaging. J Nanosci Nanotechno 11: 7521-7536, 2011.
33. Omori M, Hashi A, Nakazawa K, Yuminamochi T, Yamane T, Hirata S, Katoh R and Hoshi K: Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types. Am J Clin Pathol 128: 208-217, 2007. (Pubitemid 47262618)